JPS6245846B2 - - Google Patents

Info

Publication number
JPS6245846B2
JPS6245846B2 JP49072169A JP7216974A JPS6245846B2 JP S6245846 B2 JPS6245846 B2 JP S6245846B2 JP 49072169 A JP49072169 A JP 49072169A JP 7216974 A JP7216974 A JP 7216974A JP S6245846 B2 JPS6245846 B2 JP S6245846B2
Authority
JP
Japan
Prior art keywords
methyl
corticoid
pregnadiene
acid
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49072169A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5047967A (en, 2012
Inventor
Futsukusu Peetaa
Geruharutsu Eeritsuhi
Matsutesu Haintsu
Bento Hansu
Biihieruto Rudorufu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS5047967A publication Critical patent/JPS5047967A/ja
Publication of JPS6245846B2 publication Critical patent/JPS6245846B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP49072169A 1973-06-23 1974-06-24 Expired JPS6245846B2 (en, 2012)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2332663A DE2332663C2 (de) 1973-06-23 1973-06-23 Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie

Publications (2)

Publication Number Publication Date
JPS5047967A JPS5047967A (en, 2012) 1975-04-28
JPS6245846B2 true JPS6245846B2 (en, 2012) 1987-09-29

Family

ID=5885228

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49072169A Expired JPS6245846B2 (en, 2012) 1973-06-23 1974-06-24

Country Status (13)

Country Link
JP (1) JPS6245846B2 (en, 2012)
BE (1) BE816709A (en, 2012)
DD (1) DD112437A5 (en, 2012)
DE (1) DE2332663C2 (en, 2012)
DK (1) DK337574A (en, 2012)
ES (1) ES427480A1 (en, 2012)
FR (1) FR2233987B1 (en, 2012)
GB (1) GB1479488A (en, 2012)
IE (1) IE39516B1 (en, 2012)
IL (1) IL45087A (en, 2012)
NL (1) NL184724C (en, 2012)
SE (1) SE7408091L (en, 2012)
ZA (1) ZA744022B (en, 2012)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
DE2829953A1 (de) * 1978-07-03 1980-01-24 Schering Ag Pharmazeutische zubereitung zur behandlung der kolitis ulcerosa und kolitis granulomatosa
US5215979A (en) * 1985-12-19 1993-06-01 Aktiebolaget Draco 16,17-acetalsubstituted pregnane 21-oic acid derivatives
EP1806148A4 (en) * 2004-10-22 2009-12-02 Ono Pharmaceutical Co THERAPEUTIC PREPARATION FOR INHALATION

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB799902A (en) * 1954-08-11 1958-08-13 Merck & Co Inc Therapeutic preparations
US3320125A (en) * 1964-04-28 1967-05-16 Merck & Co Inc Inhalation aerosol composition
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1381872A (en) * 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
BE787100A (fr) * 1971-08-06 1973-02-02 Beecham Group Ltd Composition pour le traitement de l'asthme
DE2150268C3 (de) * 1971-10-04 1980-11-06 Schering Ag, 1000 Berlin Und 4619 Bergkamen Pregnansäure-Derivate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
YU35148B (en) * 1971-10-04 1980-09-25 Schering Ag Process for obtaining pregnane acid derivatives
DE2264003C2 (de) * 1972-12-22 1982-11-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue Pregnansäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2319479C2 (de) * 1973-04-14 1982-10-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Pregnansäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
AU7042174A (en) 1976-01-08
NL7408421A (en, 2012) 1974-12-30
DK337574A (en, 2012) 1975-03-17
SE7408091L (en, 2012) 1974-12-23
NL184724C (nl) 1989-10-16
ZA744022B (en) 1975-06-25
IL45087A (en) 1978-04-30
BE816709A (fr) 1974-12-23
JPS5047967A (en, 2012) 1975-04-28
DE2332663A1 (de) 1975-01-16
FR2233987A1 (en, 2012) 1975-01-17
FR2233987B1 (en, 2012) 1977-07-08
IE39516L (en) 1974-12-23
DD112437A5 (en, 2012) 1975-04-12
IL45087A0 (en) 1974-09-10
NL184724B (nl) 1989-05-16
DE2332663C2 (de) 1986-07-31
GB1479488A (en) 1977-07-13
IE39516B1 (en) 1978-10-25
ES427480A1 (es) 1976-07-16

Similar Documents

Publication Publication Date Title
US5719123A (en) Ciclosporin form for pulmonary administration
JP6219016B2 (ja) トレプロスチニル一水和物
JP3042867B2 (ja) 呼吸疾患治療薬
AU2006259604A1 (en) Substituted phenylphosphates as mutual prodrugs of steroids and beta -agonists for the treatment of pulmonary inflammation and bronchoconstriction
JP2000502365A (ja) 新規な組み合わせ
JP2006502172A (ja) 抗炎症性または抗アレルギー性アンドロスタン複合体
HU214028B (en) Process for producing cyclosporin derivatives and pharmaceutical compositions containing them
SI9210065A (en) Novel antiinflamatory and antialergic active compounds, glucocorticosteroids and processes for their preparation
JP2000501732A (ja) 抗炎症薬として有用な新規ステロイドナイトライト／ナイトレートエステル誘導体
US8258124B2 (en) Combination medicament
Boobis Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide
KR0124817B1 (ko) 4-퀴놀린 카복실산 유도체를 포함하는 피부 및 점막-상피성 질환 치료용 약제학적 조성물
JPS6245846B2 (en, 2012)
JP6366696B2 (ja) Ｓ−［４−（３−フルオロ−３−メチルブチリルオキシ）ブタ−２−イニル］６α，９α−ジフルオロ−１７α−（フラン−２−イル）カルボニルオキシ−１１β−ヒドロキシ−１６α−メチル−３−オキソアンドロスタ−１，４−ジエン−１７β−カルボチオアートを使用する炎症性病態の治療の方法
TWI309164B (en) Novel crystal form b of a known thiophenecarboxylic acid dodecahydrocyclopenta[a]phenanthrenyl ester,pharmaceutical composition comprising the same,use thereof, and method of preparing it
JPH11106339A (ja) Ｃｒ２０３９を含有する吸入用医薬組成物
CN103936808A (zh) 17β雌二醇的异烟酰胺共结晶及其制备方法和应用
JP2002510310A (ja) 抗喘息薬の新規配合
CN116270543A (zh) 脂质纳米颗粒在制备通过雾吸或鼻滴给药递送核酸的药物中的用途
US4039668A (en) Corticoid-containing inhalants
WO1994013690A1 (en) New steroids
CN1258526C (zh) 取代的β－二酮类化合物及其应用
US20060134009A1 (en) Low dose corticosteroid powders for inhalation
CN117510570A (zh) 布地奈德-21-琥珀酸酯（i）或可药用盐及应用
CN116730851A (zh) 一种维兰特罗盐型化合物及其制备方法和用途